OPK as of Nov 1 · 07:10 ET

OPKNasdaqPharmaceutical Preparations

Opko Health, Inc. · Brief

Next report

3 days

Nov 4 · after closeest.Q3 FY26

Earnings

Expected move

Inputs

±2.6%implied · report alone

1.621.70

straddle ±16.6%

spot 1.66exp Nov 20ATM strike 1.5ATM straddle 0.33IV 98%

Oct 30 closereport share · term structure

Expected move

Inputs

Implied vs realized

8 reportsHistory

1 of 8≥ implied

avg implied: ±18.7%
avg realized: ±8.0%

Nov 7 '24±19.6%▲+4.83%×0.25

Feb 27 '25±15.5%▲+6.75%×0.44

Apr 30 '25±15.2%▼−2.17%×0.14

Jul 31 '25±17.7%▼−7.03%×0.40

Oct 29 '25±13.4%▲+2.10%×0.16

Feb 26 '26±23.8%0.00%×0.00

Q1 FY26±22.6%▼−8.26%×0.37

Q2 FY26±21.7%▲+33.06%×1.53

quarterimplied−35%0+35%realized×

Q2 FY26±21.7%▲+33.06%×1.53

Q1 FY26±22.6%▼−8.26%×0.37

Feb '26±23.8%0.00%×0.00

Oct '25±13.4%▲+2.10%×0.16

Jul '25±17.7%▼−7.03%×0.40

Apr '25±15.2%▼−2.17%×0.14

2 older reports

Feb '25±15.5%▲+6.75%×0.44

Nov '24±19.6%▲+4.83%×0.25

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 4

4disclosed supplier and customer ties in SEC filingsSEC filings

3tracked funds holding OPKN-PORT · Aug 31 '26

Bear2 of 4

7 of 8recent reports where the move came in under the options implied rangeEarnings history

8 of 24largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

OPK report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 28impliedImplied move: ±14.4% into Nov 4 earnings (Oct 28 close).Source

Oct 158-KMaterial agreement: asset purchase agreement with Laboratory Corporation of America Holdings.Source

Oct 14impliedImplied move: ±64.8% into Oct 28 earnings (Oct 14 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.